Chemically inducible transcription factors are widely used to control gene expression of 20 synthetic devices. The bacterial quorum sensing system is a popular tool to achieve such 21 control. However, different quorum sensing systems have been found to cross-talk, both 22 signal in the AHL-based synthetic circuits, is leaky 19 , resulting in sometimes undesired high 54 basal expression of the output signal. 55
between themselves and with the hosts of these devices, and they are leaky by nature. Here 23 we evaluate the potential use of the γ-butyrolactone system from Streptomyces coelicolor 24 A3(2) M145 as a complementary regulatory circuit. First, two additional genes responsible 25 for the biosynthesis of γ-butyrolactones were identified in S. coelicolor M145 and then 26 expressed in E. coli BL21 under various experimental conditions. Second, the γ-27 butyrolactone receptor ScbR was optimised for expression in E. coli BL21. Finally, signal 28 and promoter crosstalk between the γ-butyrolactone system from S. coelicolor and quorum 29 sensing systems from Vibrio fischeri and Pseudomonas aeruginosa was evaluated. The 30 results show that the γ-butyrolactone system does not crosstalk with the quorum sensing 31 systems and can be used to generate orthogonal synthetic circuits. 32
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One major challenge is to develop new regulatory circuits that allow for tight regulation over 38 a wide variety of conditions 2,3 . Various tools are available to control transcript levels 4,5 , 39 translation rates 6 or protein concentration 7,8 . One popular tool is the use of chemically-40 inducible transcription factors to regulate the expression of genes of interest 3, 9 , such as the 41 acyl-homoserine lactones (AHL) from the bacterial quorum sensing (QS) system 3,10 , 42 originally derived from the microorganism Vibrio fischerii 11 . This system has been 43 previously used to generate devices such as oscillators 12 or logic gates 13 and is currently 44 being seen as a promising tool to engineer microbial consortia 10 , mainly due to the large 45 diversity of well-characterised AHL systems reported. However, despite these promising 46 applications and perspectives, different AHL devices have been found to cross-talk 14 , either 47 at the promoter or the signal level 10 ; a limitation that can result in undesirable or 48 unpredictable outcomes. Furthermore, some AHL systems control the expression of virulence 49 factors, such as the one from Pseudomonas aeruginosa 15 , and consequently organisms have 50 evolved to target these molecules using so-called quorum quenchers 16 , which function as 51 either lactonases or acylases. This can limit the application of QS systems in some hosts, such 52 as mammalian cells 17, 18 . Finally, the promoter luxp, which drives expression of the output 53 production by binding to their cognate receptor protein, a homodimer from the TetR family 66 of repressors. These repressors are the master regulators of biosynthetic gene clusters and in 67 some instances 26-28 they also regulate their own transcription and that of a GBL synthase 68 protein. 69 In this study, we evaluated the potential application of the GBL system from S. coelicolor as 70 a regulatory tool for synthetic biology in E. coli. We show that this system can be used as a 71 versatile and accessible tool to activate gene circuits in the heterologous host, with minimal 72 crosstalk with the QS systems from V. fischeri and P. aeruginosa, and that it allows for tight 73 control of genes of interest. To achieve this, we have generated a plasmid for production of 74 GBL SCB2 in E. coli and a series of plasmids constitutively expressing an optimised version 75 of ScbR and a library of Streptomyces-derived promoters: scbRp, scbAp or cpkOp, that are 76 controlling the expression of gfp. 77 78 dihydroxyacetone phosphate (DHAP) and a β-ketoacyl-acyl carrier protein (ACP) 29 , 82 followed by an intramolecular aldol condensation that yields the corresponding butenolide 83 ( Fig. 1, compound 4) . In S. coelicolor, the enzyme responsible for this catalytic step is known 84 as ScbA 26, 32 . Previous in vitro studies with homologues from Streptomyces griseus 29 and 85
Streptomyces virginiae 30 showed that after this first condensation, the butenolide is 86 enzymatically reduced in an NADPH-dependent manner to generate the reduced GBL 87 (compound 5). In some Streptomyces species, this compound undergoes a second enzymatic 88 NADPH-dependent reduction that stereo-specifically reduces the carbonyl in C 6 into an (R)-89 or (S)-alcohol 30 (compound 7). However, to our knowledge, no homologues of these 90 enzymes have been identified and characterised in S. coelicolor. Using a BLASTp search we 91 identified SCO6264 (herafter scbB, 31 % amino acid identity to BarS1 30 ) as a putative 3-92 ketoacyl-ACP/Coenzyme A (CoA) reductase from the short-chain alcohol dehydrogenase 93 superfamily and SCO6267 (hereafter scbC, 76 % amino acid identity to BprA 29 and 45 % 94 amino acid identity to BarS2 33 ) as a putative butenolide phosphate reductase. 95
To confirm the involvement of ScbB and ScbC in GBL biosynthesis, insertion mutants of 96 scbB and scbC, LW107 and LW108, respectively, were generated in S. coelicolor M145. The 97 mutant strains were grown in SFM solid medium, their GBLs extracted and analysed using 98 the kanamycin bioassay 34 (Fig. 2 ). In this assay, only spiking of ethyl acetate extracts 99 resuspended in methanol from strains that produce GBLs will be able to allow growth of 100 reporter strain LW94 in a kanamycin-supplemented medium. 101 the same retention time as observed for SCB2 (mass accuracy 0.68 ppm). The identity of the 126 compound identified in the E. coli extract was confirmed through tandem MS showing the 127 same fragmentation pattern as the obtained for SCB1 and SCB2 from S. coelicolor M145 128 ( Supplementary Fig. S3 ). None of the other GBLs produced in S. coelicolor (SCB1 and 129 SCB3) were detected. This can be explained by the fact that the β-ketoacid used in the first 130 catalytic step towards the production of GBLs derives from fatty acid biosynthesis 29, 31 . Fatty 131 acid biosynthesis starts with the decarboxylative condensation of an acyl-CoA primer with 132 malonyl-acyl carrier protein, catalysed by the gene product of fabH 35 . The S. coelicolor 133 FabH homologue preferentially uses branched acyl-CoA primers for fatty acid production, 134 such as isovaleryl-CoA and isobutyryl-CoA or metylbutyryl-CoA 36,37 , which then results in 135 production of both branched (SCB1 and SCB3) and linear (SCB2) GBLs. However, FabH 136 homologue from E. coli has a strong preference of linear acyl-CoA primers, such as acetyl-137
CoA or malonyl-CoA 38 ; thus, if the GBL precursors are derived from fatty acid biosynthesis, 138 this would result in exclusive production of linear GBLs (SCB2) in E. coli. 139
To further confirm the role of ScbB and ScbC, single knock-out mutants were generated in 140 the GBL expression plasmid, transformed and expressed in E. coli, and their extracts 141 analysed as described previously ( Fig. 3 and Supplementary Fig. S3 and Supplementary 142 Table S4 ). In the extract from E. coli harbouring scbA/C plasmid (pTE1060)), a peak was 143 detected in the EIC from the A-factor+Na adduct (theoretical m/z = 265.141028) at 144 approximately 21 min after injection, the same as A-factor from S. griseus (1.93 ppm). In 145 both extracts from S. griseus and E. coli carrying the scbA/C plasmid (pTE1060), an 146 additional broader peak is observed at approximately 20 min after injection. Further analysis 147 through tandem MS showed that both peaks contained fragments consistent with A-factor 148 ( Supplementary Fig. S3 ). In the extract from E. coli carrying scbA/B plasmid (pTE1061), 149 contrary to expectations, no peaks were detected at a mass corresponding to the non-reduced 150 butenolide precursor from A-factor (compound 4), either phosphorylated or not (data not 151 shown). However, an unidentified shunt metabolite was detected at a mass corresponding to 152 A-factor+Na adduct but eluted at an earlier retention time than A-factor. These results show 153 that by heterologous expression of the three GBL biosynthesis genes, GBLs with linear 154 residue can be produced in E. coli. 155 156 c) Production of SCB2 in E. coli BL21 is robust through different temperature and medium 157 conditions 158
Synthetic genetic circuits need to be robust under different experimental conditions to allow 159 for predictable rational design of organisms 3 . Important parameters to consider are the 160 temperature and the media conditions at which the synthetic organism is grown 39 . We tested 161 the qualitative analysis of SCB2 production in E. coli at different temperatures and in four 162 different media. Cells containing the scbA/B/C (pTE1059) plasmid were grown in either M9 163 minimal medium, LB medium, 2xYT medium or terrific broth (TB) medium and in LB at 20, 164 25, 30 and 37 °C. SCB2 production was assayed using the kanamycin bioassay. Production 165 was readily detected at assayed temperatures from 20-30 °C; however, the GBL production 166 was not detected with extracts from cells grown at 37 °C (Fig. 4 ). This is consistent with 167 previous in vitro enzyme activity results for AfsA 29 and BarS1 30 , where a reduction in 168 activity was found for both enzymes after incubation at and above 35 °C. This could be a 169 potential disadvantage when using the GBL system in E. coli. However, the thermal stability 170 and catalytic activity of the GBL biosynthetic enzymes could be achieved through random 171 mutagenesis, as has been previously shown for other enzymes 40, 41 . When E. coli harbouring 172 scbA/B/C was expressed in different media, GBLs were detected in all of the tested 173 conditions, both in minimal and rich media. Therefore, SCB2 production is robust in different 174 experimental conditions. 175 their cognate receptor. Therefore, after characterising the production of SCB2 in E. coli, we 179 proceeded to characterise the GBL receptor, ScbR, in the heterologous host. Previous reports 180 26, 42, 43 identified ScbR, and other GBL receptors, as prone to aggregate and form insoluble 181 inclusion bodies when expressed in an E. coli background. Furthermore, we, and other groups 182 44 , have attempted to crystallise GBL receptors. However, only the structures of distant 183 homologues 45, 46 , which are not known to bind GBLs, have been resolved so far. To try to 184 obtain a more soluble version of ScbR, we rationally engineered the structure, based on the 185 available structural information. Using the SWISS-MODEL suite 47 , a model structure of 186 ScbR was generated, using CprB crystal structure (PDB 1UI5 48 ) as template, and visualised 187 using the UCSF Chimera package 49 . CprB is a TetR-like DNA-binding protein from S. 188 coelicolor M145 with homology to GBL receptor proteins but unable to bind to the GBLs 189 (pseudo-receptor) 22 . The hydrophobic surface of both CprB and ScbR (33% amino acid 190 identity to CprB) was modelled and compared ( Supplementary Fig. S5 ). As expected, the 191 highly conserved N-terminus of the protein, corresponding to the DNA-binding site of the 192 protein, was similar. However, a hydrophobic patch was identified at the C-terminal end of 193 ScbR, which was not present in CprB. This hydrophobic patch was also not found in the 194 pseudo-receptor ScbR2 (35% amino acid identity to CprB) ( Supplementary Fig. S5 ). To 195 suggest possible roles of this region it was further interrogated using a docking analysis 50 , 196 which suggested that it might contain a potential GBL binding site (Supplementary Fig. 197 S6) .This suggestion would be consistent with an earlier observation 51 that showed that the 198 addition of GBLs into a crude extract containing ArpA enhanced the solubility of the protein 199 from inclusion bodies. We therefore hypothesized that GBL receptors might form inclusion 200 bodies due to interaction through this hydrophobic, putatively the GBL-binding, region. 201
Thus, to reduce the aggregation propensity, a 6x arginine tag (Arg 6 ) was added at the C-202 terminus of the protein. Addition of this tag, either at the N-or the C-terminus, has been 203 shown previously to enhance solubility of proteins without affecting their function 52,53 . 204 Recombinant ScbR-Arg 6 was expressed from plasmid ScbR-Arg 6 + luxp (pTE1067) and its 205 expression was compared to that of recombinant ScbR expressed from ScbR + luxp 206 (pTE1066) by Western Blot analysis (Fig. 5 ). In this, ScbR-Arg 6 in pTE1067 was seen to be 207 more soluble compared to ScbR. To confirm whether the soluble ScbR-Arg 6 is functional, a 208 gel shift assay using protein crude extract was performed ( Fig. 5 ). This shows that addition of 209 increasing amounts of ScbR-Arg 6 to DNA, results in appearance of two shifted bands which 210 presumably correspond to complexes of one or two ScbR-Arg 6 homodimers bound to the 211 DNA fragment containing operator sequence O R 26 ( Fig. 5 ). This result is consistent with 212 previous reports where ScbR binds its cognate operator sequence as a dimer of homodimers 213 45 and previous reported gel shift assays using recombinant ScbR 26 . Addition of SCB2 to 214 ScbR-Arg 6 resulted in release of the repressor from its cognate operator sequence (see 215 below), whereas it resulted in high variable results when SCB2 was added to untagged ScbR 216 ( Supplementary Fig. S7 ). These results suggest that addition of the Arg 6 tag at the C-terminal 217 of ScbR results in less aggregation-prone protein while retaining DNA-and GBL-binding 218 activity. 219 220 e) Crosstalk evaluation between the GBL and the AHL systems 221
As previously mentioned, a property that synthetic gene circuits aim to achieve is high 222 orthogonality, that is, that two independent genetic devices do not crosstalk 3 . It has been 223 shown that, at physiological conditions, GBLs from Streptomyces only interact with their 224 cognate receptors, although some crosstalk can be achieved at high GBL concentrations, 225 around 200 times higher than the physiological concentration 34,55 . However, to our 226 knowledge, it has not been previously explored whether the GBL system is orthogonal to the 227 more well-established signalling system based on the AHLs from V. fisheri and P. 228 aeruginosa. These systems are based on the AHLs binding to LuxR-like proteins. Upon 229 binding to their cognate AHLs, the LuxR receptors act as activators and are able to bind to 230 the corresponding operator sequence (e.g., lux box) and recruit the RNA polymerase to 231 induce transcription of a target gene ( Fig. 6 ). On the other hand, the GBL system is based on 232 the binding of the GBLs to the ScbR-like repressors. The ScbR-like receptor binds the 233 operator sequence (e.g., O R box) and represses the expression of the target gene. Once bound 234 to cognate GBLs, a conformational change occurs to the receptor and can no longer bind to 235 the operator sequence, which results in the activation of the target gene transcript. 236
Signal and promoter crosstalk were evaluated with plasmid vector BC-A1-002 54 and 237 derivatives pTE1063 to pTE1069. These plasmids contain either luxR or scbR-Arg 6 under the 238 control of a strong constitutive promoter and gfp under the control of the lux promoter (luxp) 239 (BC-A1-002 and pTE1066), the scbA promoter (scbAp) 26 (pTE1064 and pTE1069), the scbR 240 promoter (scbRp) 26 (pTE1063 and pTE1068) or the promoter of the activator of the 241 coelimycin biosynthetic cluster (cpkOp) 56 (pTE1065 and pTE1070). The GFP expression for 242 each construct was measured under different concentrations of 3-oxo-C 6 -HSL (3OC 6 ), 3-oxo-243 C 12 -HSL (3OC 12 ) and purified SCB2, obtained from E. coli supernatant as described in 244
Materials and Methods ( Supplementary Fig. S9 ) to measure the relationship between the 245 input and the response of the synthetic regulatory circuit (Fig. 7, 8) . 246
In strains with plasmids containing the luxR, addition of AHLs, either 3OC 6 or 3OC 12 , 247 resulted in activation of the luxp at concentrations above 10 -11 M or 10 -10 M, respectively, as 248 previously reported 10,54 , highlighting the cross-talk potential between the C6 and C12 AHL 249 systems. However, addition of purified SCB2 only activated luxp at concentrations above 10 -250 6 M (10 5 times higher concentration of the signal compared to 3OC 6 ). On the other hand, no 251 GFP expression was detected upon addition of any of the three signalling molecules when 252 luxR was exchanged for scbR-Arg 6 . Although we have no clear evidence, this suggests that 253
ScbR-Arg 6 does not bind to the operator sequence of LuxR. If ScbR acted as an inducer, one 254 would expect to see a decrease in GFP expression after the addition of SCB2, and if ScbR 255 acted as a repressor, one would expect to see an increase in GFP expression after addition of 256 SCB2, assuming that in both cases the DNA-binding is responsive to the SCB2 signal. We 257 see neither of these occurring. 258
The three ScbR-dependent promoters, scbRp, scbAp and cpkOp, from S. coelicolor, were 259 assayed to evaluate further the potential crosstalk with the AHL system (plasmids pTE1068 -260 pTE1070). When gfp is placed downstream of any of these promoters in plasmids containing 261 luxR, constitutive expression of GFP was observed, with or without the addition of AHLs or 262 GBL signals. This suggests that the LuxR protein does not interact with any of the tested 263 operator sequences for ScbR, and therefore the promoters are always active ( Fig. 7, 8 ). The 264 GFP expression also corresponded to the strength of the promoters which has been shown 265 before 56,57 (e.g., scbRp the strongest promoter, followed by cpkOp and scbAp).When luxR 266 was exchanged for scbR-Arg 6 , the cells only express gfp at SCB2 concentrations starting from 267 10 -9 M, reaching a maximum of induction at 10 -7 -10 -6 M. Addition of more SCB2 beyond 268 this concentration resulted in a decrease in gfp expression for scbRp or scbAp (Fig. 7, 8 ). The 269 potential toxicity of SCB2 in E. coli was discarded as the responsible of this issue, as no 270 decrease in fluorescence was seen in the strains with LuxR and those with cpkOp ( Fig. 7, 8 ) 271 and the final OD 600 was independent of the concentration of SCB2 in all samples 272 ( Supplementary Fig. S8 ). This narrow range of activity of the GBL system on these two 273 promoters has been previously seen in S. coelicolor, where exogenous addition of SCB1 274 results in precocious antibiotic production only at a narrow range of concentrations 55 . Further 275 research on the factors that influence this apparent narrow range of GBL induction would be 276 of great interest. Addition of either AHLs to plasmids containing scbR-Arg 6 resulted in no 277 expression of gfp, suggesting that ScbR does not bind to the AHLs and therefore the AHL 278 and GBL signals do not cross-talk at any concentration. 279
These results show that the GBL system from S. coelicolor does not crosstalk with the LuxR 280 system from V. fischerii and that neither the AHLs from V. fischerii nor those from P. 281 aeruginosa bind to ScbR. Furthermore, the GBL system is shown to be highly tightly 282 regulated, resulting in gfp basal expression 4-fold lower than for luxp. This could help create 283 synthetic circuit devices where tight control is required, such as multicellular decision 284 making or multi-state systems 21 . Moreover, the response obtained from the plasmids 285 containing Streptomyces-derived promoters (scbRp, scbAp and cpkOp) results in relatively 286 low maximum expression of GFP, as opposed to the high levels of expression obtained from 287 luxp, with an approximately 2-fold difference of relative strength between them (Fig. 8) . In 288 synthetic microorganisms, especially in those designed to produce speciality chemicals, fine 289 tuning and balancing of all proteins in the biosynthetic pathway has been previously shown to 290 play a crucial role in the titres produced 58, 59 The purification steps to obtain SCB2 in order to activate gene circuits can be costly and 297 time-consuming, and require specialised equipment that may not be accessible to all. To 298 overcome this limitation of the proposed system, we examined whether addition of crude 299 extract containing SCB2, without the previous purification steps, would result in activation of 300 the circuit. GBL producer strain was grown in LB medium under different temperatures, the 301 GBLs were extracted by a simple ethyl acetate extraction of the culture supernatant, 302 resuspended in different volumes of methanol and assayed against a strain containing plasmid 303 pTE1068 ( Fig. 9 ). Expression of GFP was achieved with extracts from cells grown at 20 °C 304 enriched 100-fold, and with extracts from cells grown at 25 and 30 °C enriched 500-fold. 305 need of prior complicated purification steps (e.g., by use of HPLC), making it an accessible 307 and versatile tool. 308
Interestingly, as methanol extracts are added in a 1:100 dilution to the culture with strains 309 containing the reporter plasmid pTE1068, addition of extracts enriched 100-fold corresponds 310 to a concentration of SCB2 similar to that present in the natural supernatant of the producer 311 strain before extraction. This suggests that the whole GBL system (receptor and synthases) 312 could also be used in vivo, albeit some modifications to enhance thermal stability and 313 enzymatic activity might be needed, depending on the application (e.g.; use in human cells). 314
This would then allow to generate complex circuit systems by integrating the whole system 315 inside a single cell to program a determined routine or in different cells (e.g., a sender and a 316 receiver system) to generate a synthetic ecosystems. 317 g) Towards establishing butyrolactone signalling circuits for synthetic biology 318
The generation of novel regulatory circuits that allow the assembly of predictable genetic 319 devices is one of the major challenges of synthetic biology. Currently, AHL-based circuits 320 are one of the popular choices considered when designing such devices. Here, we report the 321 first steps towards the design of the GBL system as a complementary tool for synthetic 322 regulatory circuits. The results presented are the proof-of-concept that the GBL system from 323
Streptomyces can be used in E. coli to control synthetic gene expression. An interesting area 324 of future research will be the further optimisation of the GBL biosynthetic genes through 325 directed evolution to obtain more active and thermally stable versions. This would allow 326 expression of the whole system in mammalian cells, in which GBLs have already been found 327 to be active 60 . Also of great interest would be the diversification of the GBL toolbox by 328 exploiting the modular nature of the GBL biosynthetic pathway, increasing the amount of 329 orthogonal signal systems available to control gene expression. Finally, the interesting 330 property that addition of high SCB2 concentrations results in inhibition of GFP expression 331 could potentially be used to develop genetic band-pass filters that allow expression of 332 synthetic devices only within a narrow range of inducer concentrations. 333 334 Tables S1-S3. E. coli DH5α strain was used as a host for plasmid construction and 338 maintenance; E. coli BL21 was used for protein expression and GBL production. All 339 oligonucleotides used for PCR amplification and sequencing were synthesized by IDT. 340
To construct a deletion mutant of scbB in S. coelocolor, a 3.6 kb SalI-SphI fragment 341 containing scbB (sco6264) was subcloned into pUC19 to generate pCK1. pCK1 was digested 342
with HincII and then 1.1 kb of thiostrepton-resistance gene (tsr) was inserted. The construct 343 was confirmed to have the desired deletion by DNA sequencing and restriction enzyme 344 digestion. From the resulting plasmid, the BamHI-HindIII fragment was subcloned into the 345
BamHI-HindIII-digested conjugative vector pKC1132 to generate pCK2. The plasmid pCK2 346 was transferred into S. coelicolor by conjugation via E. coli donor ET12567 (pUZ8002) to 347 generate the scbB mutant strain LW107 (ΔscbB). A deletion mutant of scbC (sco6267), 348 LW108, in S. coelicolor was constructed by inserting scbC with an apramycin resistance gene 349 and the oriT on cosmid AH10 using the PCR-targeting technology 61 resulting in a total of 15.2 mg of extract obtained. To assess the purity of the sample, the 417 extract was diluted in 1 mL of methanol and subjected to bioassay in serial dilutions of 2-418 fold. The minimum active dilution was considered to contain 0.05 µg/µL of SCB2, as 419 previously determined by Hsiao et al. 34 . This yielded an active concentration of 3.2 mg, 420 resulting in a yield of 2.2 mg/L culture. 421
e) Kanamycin Bioassays 422
Kanamycin bioassays were performed as previously described (63). Briefly, a lawn of S. 423 coelicolor LW94 was prepared in DNAgar plates supplemented with 5 µg/mL of kanamycin 424 by diluting 2.6x10 6 spores / 100 µL sterile deionised water and evenly spreading across the 425 plate. The plates were allowed to dry for three minutes at room temperature and then 2-3 µL 426 of methanol extract were spotted on the plate and allowed to dry at room temperature. Plates 427 were incubated at 30 °C for 2 -3 days and growth was monitored every 12 h. 428 volume 200 µL), centrifuged at 17,000 xg for 15 min to remove any aggregates formed and 431 transferred 150 µL of the resulting product into a glass vial. A total of 15 µL were injected 432 per sample. The solvents used were A: H 2 O + 0.1% formic acid and B: MeOH + 0.1% formic 433 acid. Both solvents were HPLC grade, from Sigma. The run conditions were 5 min isocratic 434 A:B (95:5) then gradient of 25 min to A:B (5:95), followed by isocratic 5 min A:B (5:95) in 435
an Accucore UHPLC C 18 reverse phase column (Thermo Fisher) and a Q Exactive (Thermo 436 Fisher). The ionization conditions were in positive ion mode at a spray voltage of 1.5 kV. 437 g) ScbR expression 438 Expression of ScbR was analysed using E. coli BL21 harbouring plasmids ScbR + luxp 439 (pTE1066) or ScbR-Arg 6 + luxp (pTE1067). Single colonies were grown for 16 -18 h at 37 440 °C in LB medium supplemented with 30 µg/mL of chloramphenicol. Cells were diluted 1:100 441 in LB without antibiotics and grown at 30 °C for 6 h. Cells were centrifuged at 10,000 xg and 442 4 °C for 10 min, the supernatant was discarded and the pellet homogenised by sonication in 443 buffer A 64 (50 mM sodium phosphate buffer pH 7.0, cOmplete TM tablet (Sigma)). The 444 soluble protein fraction was recovered from the supernatant after centrifugation for 20 min at 445 17,000 xg and 4 °C and the pelleted insoluble fraction was resuspended in MiliQ grade H 2 O. 446
h) SDS-PAGE and Western Blot 447
To assess protein expression, crude extracts (either soluble or insoluble fractions) were 448 resolved through SDS-PAGE (10 %(w/v), BioRad) according to Laemmli's procedure 65 . 449 Resolved bands were visualised by Coomassie blue staining (Expedeon). For Western 450 analysis, proteins resolved by SDS-PAGE gels were transferred to a polyvinylidene fluoride 451 (PVDF) membrane by semi-dry blotting. Immunodetection of His-tagged ScbA, ScbB or 452 ScbC was performed using mouse anti-His (Sigma H1029) as primary antibody and IRDye®-453 conjugated anti-mouse IgG (Abcam ab216772) as secondary antibody, and visualised using 454 LI-COR. Immunodetection of ScbR was carried out using rabbit antiserum raised against 455 ScbR 66 as primary antibody and HRP-conjugated goat anti-rabbit IgG (BioRad) as secondary 456 antibody. The substrate for chemiluminescent detection was Amersham ECL Prime (GE 457 Healthcare) and was visualised using a GeneGnome (Syngene). 458
Gel shift assays were performed as previously described 62 , using the Roche DIG Gel Shift 460 Kit (Roche). The scbRp was amplified from genomic DNA using primers scbRp_5/3, 461 generating a 144 bp fragment that was labelled with DIG according to manufacturer's 462 protocol. For each reaction, 25 ng of labelled probe were used. Where appropriate, SCB2 463 extracts were added to the mixture prior incubation. DIG-labelled DNA fragments were 464 immunodetected using antibody mouse anti-DIG (Abcam ab116590) as primary antibody and 465
IRDye®-conjugated anti-mouse IgG (Abcam ab216772) as secondary antibody, and 466 visualised using LI-COR. 467
j) Relationship between signal input and response of GBL and AHL receptors 468
Single colonies of E. coli BL21 cells containing appropriate plasmids were grown for 16 -18 469 h in LB medium with 30 µg/mL of chloramphenicol and then diluted 1:100 in M9 without 470 antibiotics and grown at 37 °C until an OD 600 0.3 -0.4, where they were aliquoted into 500 471 µL aliquots and supplemented with 1 % (v/v) of the serial dilutions of either 3OC 6 -HSL 472 (Sigma-Aldrich), 3OC 12 -HSL (Sigma-Aldrich) or SCB2 (this study) in methanol. Samples 473 were grown at 30 °C for 20 h and then transferred into a 96-well plate in triplicate (150 µL Kato et al. (29) for A-factor production in S. griseus and by Shikura et al. (30) for virginiae butanolides in S. virginiae. The biosynthesis of GBLs has been proposed to start with the condensation of DHAP with a β-ketoacid by (29, 31) ScbA in S. coelicolor A3(2), leading to product 3, which putatively undergoes a spontaneous intramolecular Claisen condensation, resulting in butenolide 4. This compound is reduced by a butenolide phosphate reductase, ScbC, yielding 5, which could be hydrolysed, yielding compound 8. The phosphate group is lost, resulting in the A-factor-like GBL 6, which can also be hydrolised to render the open lactone 9. The final GBLs (7) are obtained after stereo-specific reduction through a 3-ketoacyl-ACP/CoA reductase, ScbB. During transition phase, GBLs accumulate in the environment and bind to the receptor ScbR, resulting in a switch-like transition towards antibiotic production. coelicolor M145 extract, whereas no growth is seen for extracts from LW107 (scbA/C) and LW108 (scbA/B) mutants, suggesting these genes are involved in the production of GBLs. Extracted Ion Chromatograms (EIC) of extracts from E. coli cells expressing pTE1059 (scbA/B/C), pTE1060 (scbA/C) or pTE1061 (scbA/B). (A) When expressing the three genes using pTE1059, a EIC peak is detected that elutes at the same retention time as SCB2 from S. coelicolor M145 extract. This peak was further shown to be SCB2 by MS/MS analysis ( Supplementary Fig. S3 ). (B) After deleting scbB in pTE1060, this peak is no longer detectable; instead two peaks are detected at a mass corresponding to A-factor, which elute at the same retention time as the two peaks of A-factor from S. griseus, suggesting that scbB is responsible for the stereospecific reduction of compound 6. (C) Deletion of scbC in pTE1061 results in an unidentified detectable peak at a mass corresponding to A-factor, which elutes at a distinctive retention time. The concentration of the anhydrotetracycline (aTc) and the positive control extracts from S. coelicolor or S. griseus is denoted at the side. (D) Overlap of peaks identified in E. coli ethyl acetate extracts showed in panels A -C, highlighting the distinctive retention time between them. Normalised GFP/OD 600 output after addition of different concentrations of autoinducer concentrations ([AI]/M), either 3OC 6 HSL (blue line), 3OC 12 HSL (green line) or SCB2 (red line); to strains harbouring plasmids BC-A1-002 (LuxR+luxp), pTE1063 (LuxR+scbRp), pTE1067 (ScbR-Arg 6 +luxp) and pTE1068 (ScbR-Arg 6 +scbRp) ( Fig 6) . Measurements were made ~20 h after induction and growth at 30 °C. Expression of gfp is at the maximum with concentrations of 10 −9 M of 3OC6-HSL and 10 −8 M of 3OC12-HSL, when added to BC-A1-002. However, no GFP expression is seen when AHLs are added to the cells with the ScbR-Arg 6 +luxp (pTE1067). On the other hand, addition of any signalling molecules results in no change in gfp expression in LuxR+scbRp (pTE1063), where scbRp is always active. GFP expression is induced upon the addition of SCB2 with the ScbR-Arg 6 +scbRp (pTE1068). Interestingly, addition of an excess of SCB2 in ScbR-Arg 6 +scbRp results in repression of the system. No induction of GFP was observed with addition of AHLs to ScbR-Arg 6 +scbRp (pTE1068).
Figure 8
Figure 8. Expression of GFP with different ScbR-dependent promoters results in a gradient of output signal. Normalised GFP/OD 600 output after addition of different concentrations of autoinducer ([AI]/M) 3OC 6 HSL (blue line) or SCB2 (red line); to strains harbouring pTE1063 (LuxR + scbRp), pTE1064 (LuxR + scbAp), pTE1065 (LuxR + cpkOp), pTE1068 (ScbR-Arg 6 + scbRp), pTE1069 (ScbR-Arg 6 + scbAp) or pTE1070 (ScbR-Arg 6 + cpkOp). Measurements were made ~20 h after induction and growth at 30 °C. As seen in Fig  7, plasmids containing LuxR are active at all concentrations of signals, suggesting that LuxR does not interact with any of the ScbR operator sequences to repress the promoters. Exchange of luxR for scbR-Arg6 results in repression of the promoters until around 10 −9 M of SCB2. Interestingly, both scbRp and scbAp are only active in concentrations between 10 -8 to 10 -4 Mof SCB2, respectively. However, cpkOp is active at all concentrations above 10 −9 M, and the activity was not shut down. The results match the previously observed characteristics, where lower temperatures seem to be favourable for SCB2 production (Fig.  3) . Interestingly, addition of a 100-fold concentrated ethyl acetate extracts of the liquid culture supernatant to the reporter cells (shaded box) resulted in full activation of gfp expression at 20 °C and about half activation of gfp expression at 25 and 30 °C, suggesting that the system could be used at different temperatures to fine tune gene expression.
